Pre-emptive treatment of hepatitis B infection by lamivudine in two Tunisian renal transplant recipients.
Infection with hepatitis B virus has a major implication for transplant recipients due to the risk of reactivation under immunosuppression, progression to chronic liver disease, development of liver cirrhosis and hepatocellular carcinoma. We report two cases of renal transplantation patients who were hepatitis B surface antigen positive before transplantation and were treated by Lamivudine.
Unity of Organ Transplantation, Military Hospital of Tunis, Tunis, Tunisia.
Kais
K
Harzallah
Wafa
W
Haddad
Mondher
M
Haloues
Imene
I
El Kossai
Nabil Ben
NB
Romdhane
Hatem Ben
HB
Abdallah
Riadh
R
Bouali
Mohamed Nabil
MN
Abdelli
Jalel
J
Hmida
Jamel
J
Manaa
D000328:Adult; D018450:Disease Progression; D005260:Female; D006509:Hepatitis B / Q000517:prevention & control*; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D014416:Tunisia
D006514:Hepatitis B Surface Antigens; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine